The webinar discussion will identify and define essential factors needed to create a sustainable cell and gene therapy (CGT) ecosystem, uniting pharmaceutical manufacturers, providers, payers, and other stakeholders. While the science of CGT has advanced, the components of drug launch including commercialization are straggling behind, creating challenges with stakeholder engagement, supply chain and patient access.